Sunitinib malate is a salt form of sunitinib, an organic molecular entity that acts as an antineoplastic agent and an inhibitor of receptor protein-tyrosine kinase (EC 2. 7.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 341031-54-7
Sunitinib
pharmaceutical raw material
Trimebutine maleate
pharmaceutical raw material
Glycodehydrocholic acid
pharmaceutical raw material
Propafenone hydrochloride
pharmaceutical raw material
(2R,3R,4R)-Alvimopan
pharmaceutical raw material
(E)-Sunitinib
pharmaceutical raw material
5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
pharmaceutical intermediate
3-[(3-(2-carboxyethyl)-4-methylpyrrol-2-yl)methylene]-2-indolinone
research compound
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid
LBWFXVZLPYTWQI-IPOVEDGCSA-N
CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C.C([C@@H](C(=O)O)O)C(=O)O